Top Chinese Think Tank Visits Boston for Study on Health Information Technology
28 November 2018
Earlier this month, Boston Healthcare Associates hosted a delegation from the China Development Research Foundation (CDRF), a public foundation initiated by the Development Research Center of the State Council of the People’s Republic of China, with the mission to provide policy research support for policy making on a national level.
CDRF supports evidence-based policy research, leadership training, high-level forums and symposiums to promote economic cooperation and development, and the promotion of responsible public policy.
The delegation visited Boston to learn more about the role that Health Information Technology (HIT) plays in the healthcare system, how its development has progressed, and future opportunities for improving efficiency and quality of care. Boston, as a global leader in the healthcare and life sciences industry, and home to some of the world’s leading hospitals and community health centers, health IT, and digital health companies, was chosen as one of the field study sites.
The delegation heard from innovative leaders in the HIT space from Partner’s Healthcare, Watson Health, and Harvard Pilgrim Healthcare on day one of the trip during a half day Forum at the Royal Sonesta in Cambridge. Speakers provided the delegation with an in-depth overview of the application of health information technology in healthcare delivery and management.
While in Boston, the delegation also visited and toured Boston Children’s Hospital, the MIT-IBM Watson AI Lab, and Massachusetts General Hospital.
With the Chinese government seeking to improve efficiency and quality of healthcare services and health insurance, especially at the community level, the exchange of information between innovative health organizations is timely.
Boston Healthcare has a deep understanding of the evolving value and access landscape in China. Please contact us for more information.
In Germany, doctors could potentially be prescribing health apps as medicines as early as 2020. This is one of the main objectives of the draft bill on the “Law for better provision through digitalization and innovation”, which is expected to be approved by the parliament early November.
Medical Disposables & Consumables Players Face Challenge of Government-Initiated Price Cuts in China
When the Chinese government started to slash the drug prices in 2018, we knew that it was only a matter of time before medical consumables would be affected.
Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany
In the past, the inclusion of new diagnostic tests in the EBM was not transparent, with unclear timelines and requirements and manufacturers were unable to...